1. Home
  2. STWD vs SRRK Comparison

STWD vs SRRK Comparison

Compare STWD & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STWD

STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

HOLD

Current Price

$18.11

Market Cap

6.4B

Sector

Real Estate

ML Signal

HOLD

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$49.02

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STWD
SRRK
Founded
2009
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.6B
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
STWD
SRRK
Price
$18.11
$49.02
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$20.13
$55.64
AVG Volume (30 Days)
2.9M
1.7M
Earning Date
05-08-2026
05-13-2026
Dividend Yield
10.58%
N/A
EPS Growth
4.55
N/A
EPS
1.15
N/A
Revenue
$1,844,289,000.00
N/A
Revenue This Year
$283.44
N/A
Revenue Next Year
$17.66
$544.77
P/E Ratio
$15.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.90
$27.07
52 Week High
$20.99
$51.63

Technical Indicators

Market Signals
Indicator
STWD
SRRK
Relative Strength Index (RSI) 60.90 57.33
Support Level $17.64 $42.52
Resistance Level $18.62 $51.63
Average True Range (ATR) 0.25 1.92
MACD 0.12 0.18
Stochastic Oscillator 91.92 73.07

Price Performance

Historical Comparison
STWD
SRRK

About STWD STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

Starwood Property Trust Inc is a real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans, commercial mortgage-backed securities, and other real estate investments in the U.S., Australia, and Europe. The company has four reportable business segments: Commercial and Residential Lending, Infrastructure Lending, Property, and Investing and Servicing. The majority of its revenue is generated from the Commercial and Residential Lending segment, which engages mainly in originating, acquiring, financing, and managing commercial first mortgages, non-agency residential mortgages (residential loans), commercial mortgage-backed securities (CMBS), residential mortgage-backed securities (RMBS), and other real estate and related debt investments.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Share on Social Networks: